Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Allergy and Clinical Immunology|July 2, 2011
The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challengeGrant C Nicholson, Harsha H Kariyawasam, Andrew J Tan, et al.Plos One|November 9, 2013
Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypesNicolai A Kittan, Ronald M Allen, Abhay Dhaliwal, et al.American Journal of Respiratory Cell and Molecular Biology|October 22, 2009
Expression of transient receptor potential C6 channels in human lung macrophagesTricia K Finney-Hayward, Mariana Oana Popa, Parmjit Bahra, et al.American Journal of Respiratory and Critical Care Medicine|October 23, 2012
Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expressionLoredana Ciuclan, Martin J Hussey, Victoria Burton, et al.Science Translational Medicine|October 3, 2014
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammationJanine Beale, Annabelle Jayaraman, David J Jackson, et al.Frontiers in Pharmacology|May 23, 2017
Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related HydroxylasesMike Petrassi, Rob Barber, Celine Be, et al.Science Translational Medicine|November 12, 2010
TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosisGlenda Trujillo, Alessia Meneghin, Kevin R Flaherty, et al.Ebiomedicine|April 5, 2017
A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13)Trevor T Hansel, Tanushree Tunstall, Maria-Belen Trujillo-Torralbo, et al.Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.American Journal of Respiratory and Critical Care Medicine|October 29, 2014
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivoDavid J Jackson, Heidi Makrinioti, Batika M J Rana, et al.Pageof 4